Menu
ETF
Annual · values2025202420232022202120202019
Operating Cash Flow-24.59 M USD-26.54 M USD-36.31 M USD-61.76 M USD-32.68 M USD-582527 USD
Depreciation & Amortization6.94 M USD6.29 M USD5.87 M USD4.41 M USD3.34 M USD3.18 M USD
Stock-Based Compensation4.55 M USD11.15 M USD17.81 M USD27.68 M USD24.54 M USD151000 USD
Capital Expenditures3.20 M USD3.79 M USD4.57 M USD5.53 M USD2.85 M USD1.19 M USD
Cash Flow from Investing-3.07 M USD46.21 M USD62.64 M USD-131.61 M USD-12.15 M USD-230.00 M USD
Cash Flow from Financing11.56 M USD-3.49 M USD-6.85 M USD92.21 M USD154.01 M USD231.47 M USD
Dividends Paid
Stock Buybacks0 USD1.02 M USD9.00 M USD0 USD
Free Cash Flow-27.79 M USD-30.33 M USD-40.88 M USD-67.28 M USD-35.53 M USD-1.78 M USD

The Oncology Institute, Inc. is a value-based community oncology group providing comprehensive cancer care treatment services across multiple settings. Operating through three primary segments—Dispensary, Patient Care, and Clinical Trials and Other—the company delivers specialized oncology services including infusion centers, in-house pharmaceutical dispensary, outpatient blood transfusions, outpatient stem cell transplants, financial counseling, clinical trials, comprehensive laboratory testing, and end-of-life counseling. With over 100 employed clinicians and more than 800 team members operating across numerous clinic locations, The Oncology Institute serves a large patient population with evidence-based, high-quality cancer care. Founded in 2007 and headquartered in Cerritos, California, the company focuses on advancing oncology through value-based care models designed to improve patient outcomes while optimizing healthcare delivery in community settings rather than traditional hospital environments.